<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03639792</url>
  </required_header>
  <id_info>
    <org_study_id>RJ-GC-Postop-complication 2</org_study_id>
    <nct_id>NCT03639792</nct_id>
  </id_info>
  <brief_title>Escorting Octogenarian for Gastric Cancer Surgery</brief_title>
  <official_title>Escorting Octogenarian for Gastric Cancer Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ruijin Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ruijin Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An objective analysis of postoperative complications is vital to escort octogenarian for
      gastric cancer surgery. Investigator carefully collected clinical data prospectively to pave
      way for standard management in high risk patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An objective analysis of postoperative complications is vital to escort octogenarian for
      gastric cancer surgery. Investigator carefully collected clinical data prospectively to pave
      way for standard management in high risk patients. Detailed data on surgical indication,
      assessment for proposed surgery and perioperative management are analyzed for future
      guidelines in senile.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative Morbidity and mortality</measure>
    <time_frame>One month after hospital discharge</time_frame>
    <description>Postoperative Morbidity and mortality according to standard definition</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>upto two years</time_frame>
    <description>Overall survival</description>
  </secondary_outcome>
  <enrollment type="Actual">61</enrollment>
  <condition>Gastric Cancer</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>gastric cancer surgery</intervention_name>
    <description>Gastric cancer surgery</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A cohort of gastric cancer patients who underwent surgery during two consecutive years in a
        Chinese hospital.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Pathologically confirmed gastric cancer patients Clinically fit for gastric cancer
        surgery

        Exclusion Criteria:

        - Non gastric cancer patients Clinically unfit for gastric cancer surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>80 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Birendra K Sah, Ph D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ruijin Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ruijin Hospital Shanghai Jiaotong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200025</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 17, 2018</study_first_submitted>
  <study_first_submitted_qc>August 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2018</study_first_posted>
  <last_update_submitted>May 21, 2020</last_update_submitted>
  <last_update_submitted_qc>May 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ruijin Hospital</investigator_affiliation>
    <investigator_full_name>BIRENDRA KUMAR SAH</investigator_full_name>
    <investigator_title>Surgeon</investigator_title>
  </responsible_party>
  <keyword>gastric cancer</keyword>
  <keyword>postoperative complication</keyword>
  <keyword>octogenarian</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

